Skip to main content
. 2023 May 20;11(3):87. doi: 10.3390/pharmacy11030087

Table 2.

Molnupiravir (Lagevrio) pharmacy assessment checklist.

Molnupiravir (Lagevrio): Pharmacy Assessment
1 Date of symptom onset
(Must be within 5 days of filling)
2 High-risk condition(s)
(Patients must have one or more high-risk conditions defined by the CDC)
3 Pregnancy Status
(Must not be actively pregnant)
4 Pharmacy Interventions
(List any pharmacist interventions made)